chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Headache, Pyrexia
Clinical narrative: weakness; chills; high fever; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), CHILLS (chills), PYREXIA (high fever), HEADACHE (headache) and PYREXIA (fever) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 026B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weakness), CHILLS (chills), PYREXIA (high fever), HEADACHE (headache) and PYREXIA (fever). At the time of the report, ASTHENIA (weakness), CHILLS (chills), PYREXIA (high fever), HEADACHE (headache) and PYREXIA (fever) outcome was unknown.            concomitant medication includes iron supplement. No treatment drugs are not provided by reporter.   This case was linked to MOD-2021-106571 (Patient Link).
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Gait disturbance, Muscle discomfort, Pain, Pain in extremity
Clinical narrative: Injection site redness; Injection site itchiness; could barely walk; Feels like she pulled a muscle; back and legs have been aching since, back and legs hurt really bad, felt like she pulled a muscle; back and legs have been aching since, back and legs hurt really bad, felt like she pulled a muscle; Pain returns with exertion; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (could barely walk), MUSCLE DISCOMFORT (Feels like she pulled a muscle), PAIN IN EXTREMITY (back and legs have been aching since, back and legs hurt really bad, felt like she pulled a muscle), BACK PAIN (back and legs have been aching since, back and legs hurt really bad, felt like she pulled a muscle) and PAIN (Pain returns with exertion) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LAMOTRIGINE for Bipolar disorder, MIRTAZAPINE (MIRTAZEPINE TEVA), ZOLPIDEM, SERTRALINE, HYDROCODONE BITARTRATE, PARACETAMOL (NORCO), ONDANSETRON and ACETYLSALICYLIC ACID, CARISOPRODOL (SOMA CMPD) for an unknown indication.    On 01-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced GAIT DISTURBANCE (could barely walk), MUSCLE DISCOMFORT (Feels like she pulled a muscle), PAIN IN EXTREMITY (back and legs have been aching since, back and legs hurt really bad, felt like she pulled a muscle), BACK PAIN (back and legs have been aching since, back and legs hurt really bad, felt like she pulled a muscle) and PAIN (Pain returns with exertion). On 05-May-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection site redness) and VACCINATION SITE PRURITUS (Injection site itchiness). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, GAIT DISTURBANCE (could barely walk), MUSCLE DISCOMFORT (Feels like she pulled a muscle), PAIN IN EXTREMITY (back and legs have been aching since, back and legs hurt really bad, felt like she pulled a muscle), BACK PAIN (back and legs have been aching since, back and legs hurt really bad, felt like she pulled a muscle), PAIN (Pain returns with exertion), VACCINATION SITE ERYTHEMA (Injection site redness) and VACCINATION SITE PRURITUS (Injection site itchiness) outcome was unknown. Not Provided          This case was linked to MOD-2021-106661 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Added new events. On 22-Jul-2021: TCR received contains no new information
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Injection site redness; Injection site itchiness; could barely walk; Feels like she pulled a muscle; back and legs have been aching since, back and legs hurt really bad, felt like she pulled a muscle; back and legs have been aching since, back and legs hurt really bad, felt like she pulled a muscle; Pain returns with exertion; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (could barely walk), MUSCLE DISCOMFORT (Feels like she pulled a muscle), PAIN IN EXTREMITY (back and legs have been aching since, back and legs hurt really bad, felt like she pulled a muscle), BACK PAIN (back and legs have been aching since, back and legs hurt really bad, felt like she pulled a muscle) and PAIN (Pain returns with exertion) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LAMOTRIGINE for Bipolar disorder, MIRTAZAPINE (MIRTAZEPINE TEVA), ZOLPIDEM, SERTRALINE, HYDROCODONE BITARTRATE, PARACETAMOL (NORCO), ONDANSETRON and ACETYLSALICYLIC ACID, CARISOPRODOL (SOMA CMPD) for an unknown indication.    On 01-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced GAIT DISTURBANCE (could barely walk), MUSCLE DISCOMFORT (Feels like she pulled a muscle), PAIN IN EXTREMITY (back and legs have been aching since, back and legs hurt really bad, felt like she pulled a muscle), BACK PAIN (back and legs have been aching since, back and legs hurt really bad, felt like she pulled a muscle) and PAIN (Pain returns with exertion). On 05-May-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection site redness) and VACCINATION SITE PRURITUS (Injection site itchiness). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, GAIT DISTURBANCE (could barely walk), MUSCLE DISCOMFORT (Feels like she pulled a muscle), PAIN IN EXTREMITY (back and legs have been aching since, back and legs hurt really bad, felt like she pulled a muscle), BACK PAIN (back and legs have been aching since, back and legs hurt really bad, felt like she pulled a muscle), PAIN (Pain returns with exertion), VACCINATION SITE ERYTHEMA (Injection site redness) and VACCINATION SITE PRURITUS (Injection site itchiness) outcome was unknown. Not Provided          This case was linked to MOD-2021-106661 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Added new events. On 22-Jul-2021: TCR received contains no new information
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Paraesthesia oral, Pruritus, Rash, Vaccination site reaction
Clinical narrative: She reported that her arm where the injection was also "whelped" up.; lips numb and tingly; lips numb and tingly; stomach rash and itching; full body itching; stomach rash and itching; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (lips numb and tingly), PARAESTHESIA ORAL (lips numb and tingly), PRURITUS (stomach rash and itching), PRURITUS (full body itching) and RASH (stomach rash and itching) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, the patient experienced HYPOAESTHESIA ORAL (lips numb and tingly), PARAESTHESIA ORAL (lips numb and tingly), PRURITUS (stomach rash and itching), PRURITUS (full body itching) and RASH (stomach rash and itching). On an unknown date, the patient experienced VACCINATION SITE REACTION (She reported that her arm where the injection was also "whelped" up.). On 04-Apr-2021, HYPOAESTHESIA ORAL (lips numb and tingly) and PARAESTHESIA ORAL (lips numb and tingly) had resolved. On 08-Apr-2021, PRURITUS (stomach rash and itching) outcome was unknown, PRURITUS (full body itching) and RASH (stomach rash and itching) had resolved. At the time of the report, VACCINATION SITE REACTION (She reported that her arm where the injection was also "whelped" up.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drugs were reported. No treatment drugs are not provided by reporter.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine was used beyond the 12 hours expiration date; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine was used beyond the 12 hours expiration date) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine was used beyond the 12 hours expiration date). On 05-May-2021, EXPIRED PRODUCT ADMINISTERED (vaccine was used beyond the 12 hours expiration date) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    This case was linked to US-MODERNATX, INC.-MOD-2021-106540 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: follow-up was received on 05-MAY-2021 contain no new information On 10-May-2021: follow-up was received on 10-may-2021 and updated date of first Moderna Covid-19 vaccine dose was recorded; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-106540:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Lymphadenopathy, Oral discomfort, Pain in jaw
Clinical narrative: not feeling well; could not open mouth; jaw soreness; swollen lymph node; This spontaneous case was reported by a consumer and describes the occurrence of ORAL DISCOMFORT (could not open mouth), PAIN IN JAW (jaw soreness), FEELING ABNORMAL (not feeling well) and LYMPHADENOPATHY (swollen lymph node) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced PAIN IN JAW (jaw soreness) and LYMPHADENOPATHY (swollen lymph node). On 30-Mar-2021, the patient experienced ORAL DISCOMFORT (could not open mouth). On an unknown date, the patient experienced FEELING ABNORMAL (not feeling well). The patient was treated with AMOXICILLIN at an unspecified dose and frequency and BENZYLPENICILLIN SODIUM (PENICILLIN [BENZYLPENICILLIN SODIUM]) at an unspecified dose and frequency. At the time of the report, ORAL DISCOMFORT (could not open mouth), PAIN IN JAW (jaw soreness), FEELING ABNORMAL (not feeling well) and LYMPHADENOPATHY (swollen lymph node) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other treatment information included Corticosteroids. Concomitant medications were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in the Left arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the Left arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced PAIN IN EXTREMITY (Pain in the Left arm). In 2021, PAIN IN EXTREMITY (Pain in the Left arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Relevant concomitant medications was reported.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-106601 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-106601:
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Illness, Pain in extremity
Clinical narrative: sick; Soreness in his arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in his arm) and ILLNESS (sick) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     Concomitant products included BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (BIKTARVY) for an unknown indication.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (Soreness in his arm). On 04-May-2021, the patient experienced ILLNESS (sick). On 15-Apr-2021, PAIN IN EXTREMITY (Soreness in his arm) had resolved. At the time of the report, ILLNESS (sick) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment drugs are not provided by reporter. ADHD medications and HIV medications includes in concomitant medications.   This case was linked to MOD-2021-106811 (Patient Link).
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Malaise, Pain, Pyrexia
Clinical narrative: persistent cough; malaise; pain; fever; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (persistent cough), MALAISE (malaise), PAIN (pain) and PYREXIA (fever) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced COUGH (persistent cough), MALAISE (malaise), PAIN (pain) and PYREXIA (fever). On 23-Apr-2021, MALAISE (malaise), PAIN (pain) and PYREXIA (fever) had resolved. At the time of the report, COUGH (persistent cough) outcome was unknown. Not Provided          Action taken with response to the events were not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Chills, Headache, Pyrexia
Clinical narrative: bone pain; chills; fever; headache pain; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (bone pain), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced BONE PAIN (bone pain), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache pain). At the time of the report, BONE PAIN (bone pain), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment medications was not given.   This case was linked to US-MODERNATX, INC.-MOD-2021-107093 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-107093:
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Dose Administration Error (Invalid Dose); This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (Dose Administration Error (Invalid Dose)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced INCORRECT DOSE ADMINISTERED (Dose Administration Error (Invalid Dose)). At the time of the report, INCORRECT DOSE ADMINISTERED (Dose Administration Error (Invalid Dose)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-106851, US-MODERNATX, INC.-MOD-2021-106777, US-MODERNATX, INC.-MOD-2021-106844 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-106851:crosslinked US-MODERNATX, INC.-MOD-2021-106777:crosslinked US-MODERNATX, INC.-MOD-2021-106844:crosslinked
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: extreme pain at the injection site of her right arm for 24-48 hours; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (extreme pain at the injection site of her right arm for 24-48 hours) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     Concomitant products included FLUOXETINE, PROPRANOLOL, TRAZODONE, ACETIC ACID, TRETINOIN, MULTI VITAMIN & MINERAL, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), CLINDAMYCIN and SULFAMETHOXAZOLE for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced VACCINATION SITE PAIN (extreme pain at the injection site of her right arm for 24-48 hours). At the time of the report, VACCINATION SITE PAIN (extreme pain at the injection site of her right arm for 24-48 hours) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   This case was linked to MOD-2021-106743 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling of relaxation, Somnolence, Vaccination site discolouration, Vaccination site erythema
Clinical narrative: feels better after she takes a nap; Vaccination site discoloration; felt sleepy; Tiredness; Vaccination site erythema; Vaccination site pain; Vaccination site swelling; This spontaneous case was reported by a consumer and describes the occurrence of FEELING OF RELAXATION (feels better after she takes a nap), VACCINATION SITE DISCOLOURATION (Vaccination site discoloration), SOMNOLENCE (felt sleepy), FATIGUE (Tiredness) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21-2A and 042B21-21) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (The patient have allergy towards azithromycin and sulfa drugs. Azithromycin makes the patient vomit.).   On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced FEELING OF RELAXATION (feels better after she takes a nap), VACCINATION SITE DISCOLOURATION (Vaccination site discoloration), SOMNOLENCE (felt sleepy), FATIGUE (Tiredness), VACCINATION SITE ERYTHEMA (Vaccination site erythema), VACCINATION SITE PAIN (Vaccination site pain) and VACCINATION SITE SWELLING (Vaccination site swelling). At the time of the report, FEELING OF RELAXATION (feels better after she takes a nap), VACCINATION SITE DISCOLOURATION (Vaccination site discoloration), SOMNOLENCE (felt sleepy), FATIGUE (Tiredness), VACCINATION SITE ERYTHEMA (Vaccination site erythema), VACCINATION SITE PAIN (Vaccination site pain) and VACCINATION SITE SWELLING (Vaccination site swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was given. No laboratory details was given. No treatment information was given. Patient had same adverse events like swelling, sleeping , tiredness after 2nd dose of vaccination but along with that she had itching too.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up received on 24 May 2021 contain significant information of history and second dose information
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: feels better after she takes a nap; Vaccination site discoloration; felt sleepy; Tiredness; Vaccination site erythema; Vaccination site pain; Vaccination site swelling; This spontaneous case was reported by a consumer and describes the occurrence of FEELING OF RELAXATION (feels better after she takes a nap), VACCINATION SITE DISCOLOURATION (Vaccination site discoloration), SOMNOLENCE (felt sleepy), FATIGUE (Tiredness) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21-2A and 042B21-21) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (The patient have allergy towards azithromycin and sulfa drugs. Azithromycin makes the patient vomit.).   On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced FEELING OF RELAXATION (feels better after she takes a nap), VACCINATION SITE DISCOLOURATION (Vaccination site discoloration), SOMNOLENCE (felt sleepy), FATIGUE (Tiredness), VACCINATION SITE ERYTHEMA (Vaccination site erythema), VACCINATION SITE PAIN (Vaccination site pain) and VACCINATION SITE SWELLING (Vaccination site swelling). At the time of the report, FEELING OF RELAXATION (feels better after she takes a nap), VACCINATION SITE DISCOLOURATION (Vaccination site discoloration), SOMNOLENCE (felt sleepy), FATIGUE (Tiredness), VACCINATION SITE ERYTHEMA (Vaccination site erythema), VACCINATION SITE PAIN (Vaccination site pain) and VACCINATION SITE SWELLING (Vaccination site swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was given. No laboratory details was given. No treatment information was given. Patient had same adverse events like swelling, sleeping , tiredness after 2nd dose of vaccination but along with that she had itching too.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up received on 24 May 2021 contain significant information of history and second dose information
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Contusion, Diarrhoea, Lymphadenopathy, Migraine
Clinical narrative: diarrhea; weight loss; migraine headache lasting for 3days; swollen left arm; bruises; Covid arm; chest and neck area were all swollen; sick in the stomach; rash; nausea; swollen lymph node; slept all day; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), WEIGHT DECREASED (weight loss), MIGRAINE (migraine headache lasting for 3days), PERIPHERAL SWELLING (swollen left arm) and CONTUSION (bruises) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ETHINYLESTRADIOL, FERROUS FUMARATE, NORETHISTERONE ACETATE (LARIN FE), CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), VENLAFAXINE, LANSOPRAZOLE, TIZANIDINE HCL, BUSPIRONE, POTASSIUM, MAGNESIUM, ZINC, VITAMIN B NOS (B-COMPLEX [VITAMIN B NOS]), Butterbur, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and DUPILUMAB (DUPIXENT) for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced SOMNOLENCE (slept all day). On 26-Apr-2021, the patient experienced DIARRHOEA (diarrhea), WEIGHT DECREASED (weight loss), MIGRAINE (migraine headache lasting for 3days), PERIPHERAL SWELLING (swollen left arm), CONTUSION (bruises), VACCINATION COMPLICATION (Covid arm), SWELLING (chest and neck area were all swollen), ABDOMINAL DISCOMFORT (sick in the stomach), RASH (rash), NAUSEA (nausea) and LYMPHADENOPATHY (swollen lymph node). On 25-Apr-2021, SOMNOLENCE (slept all day) outcome was unknown. On 29-Apr-2021, WEIGHT DECREASED (weight loss) had resolved. At the time of the report, DIARRHOEA (diarrhea), MIGRAINE (migraine headache lasting for 3days), PERIPHERAL SWELLING (swollen left arm), CONTUSION (bruises), VACCINATION COMPLICATION (Covid arm), SWELLING (chest and neck area were all swollen), ABDOMINAL DISCOMFORT (sick in the stomach), RASH (rash), NAUSEA (nausea) and LYMPHADENOPATHY (swollen lymph node) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication includes Took Pepcid, Benadryl, Nauzene, and Ondansetron.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable   This case was linked to MOD-2021-106665 (Patient Link).
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Peripheral swelling, Rash, Somnolence, Swelling
Clinical narrative: diarrhea; weight loss; migraine headache lasting for 3days; swollen left arm; bruises; Covid arm; chest and neck area were all swollen; sick in the stomach; rash; nausea; swollen lymph node; slept all day; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), WEIGHT DECREASED (weight loss), MIGRAINE (migraine headache lasting for 3days), PERIPHERAL SWELLING (swollen left arm) and CONTUSION (bruises) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ETHINYLESTRADIOL, FERROUS FUMARATE, NORETHISTERONE ACETATE (LARIN FE), CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), VENLAFAXINE, LANSOPRAZOLE, TIZANIDINE HCL, BUSPIRONE, POTASSIUM, MAGNESIUM, ZINC, VITAMIN B NOS (B-COMPLEX [VITAMIN B NOS]), Butterbur, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and DUPILUMAB (DUPIXENT) for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced SOMNOLENCE (slept all day). On 26-Apr-2021, the patient experienced DIARRHOEA (diarrhea), WEIGHT DECREASED (weight loss), MIGRAINE (migraine headache lasting for 3days), PERIPHERAL SWELLING (swollen left arm), CONTUSION (bruises), VACCINATION COMPLICATION (Covid arm), SWELLING (chest and neck area were all swollen), ABDOMINAL DISCOMFORT (sick in the stomach), RASH (rash), NAUSEA (nausea) and LYMPHADENOPATHY (swollen lymph node). On 25-Apr-2021, SOMNOLENCE (slept all day) outcome was unknown. On 29-Apr-2021, WEIGHT DECREASED (weight loss) had resolved. At the time of the report, DIARRHOEA (diarrhea), MIGRAINE (migraine headache lasting for 3days), PERIPHERAL SWELLING (swollen left arm), CONTUSION (bruises), VACCINATION COMPLICATION (Covid arm), SWELLING (chest and neck area were all swollen), ABDOMINAL DISCOMFORT (sick in the stomach), RASH (rash), NAUSEA (nausea) and LYMPHADENOPATHY (swollen lymph node) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication includes Took Pepcid, Benadryl, Nauzene, and Ondansetron.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable   This case was linked to MOD-2021-106665 (Patient Link).
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Weight decreased
Clinical narrative: diarrhea; weight loss; migraine headache lasting for 3days; swollen left arm; bruises; Covid arm; chest and neck area were all swollen; sick in the stomach; rash; nausea; swollen lymph node; slept all day; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), WEIGHT DECREASED (weight loss), MIGRAINE (migraine headache lasting for 3days), PERIPHERAL SWELLING (swollen left arm) and CONTUSION (bruises) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ETHINYLESTRADIOL, FERROUS FUMARATE, NORETHISTERONE ACETATE (LARIN FE), CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), VENLAFAXINE, LANSOPRAZOLE, TIZANIDINE HCL, BUSPIRONE, POTASSIUM, MAGNESIUM, ZINC, VITAMIN B NOS (B-COMPLEX [VITAMIN B NOS]), Butterbur, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and DUPILUMAB (DUPIXENT) for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced SOMNOLENCE (slept all day). On 26-Apr-2021, the patient experienced DIARRHOEA (diarrhea), WEIGHT DECREASED (weight loss), MIGRAINE (migraine headache lasting for 3days), PERIPHERAL SWELLING (swollen left arm), CONTUSION (bruises), VACCINATION COMPLICATION (Covid arm), SWELLING (chest and neck area were all swollen), ABDOMINAL DISCOMFORT (sick in the stomach), RASH (rash), NAUSEA (nausea) and LYMPHADENOPATHY (swollen lymph node). On 25-Apr-2021, SOMNOLENCE (slept all day) outcome was unknown. On 29-Apr-2021, WEIGHT DECREASED (weight loss) had resolved. At the time of the report, DIARRHOEA (diarrhea), MIGRAINE (migraine headache lasting for 3days), PERIPHERAL SWELLING (swollen left arm), CONTUSION (bruises), VACCINATION COMPLICATION (Covid arm), SWELLING (chest and neck area were all swollen), ABDOMINAL DISCOMFORT (sick in the stomach), RASH (rash), NAUSEA (nausea) and LYMPHADENOPATHY (swollen lymph node) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication includes Took Pepcid, Benadryl, Nauzene, and Ondansetron.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable   This case was linked to MOD-2021-106665 (Patient Link).
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypersomnia, Vaccination site pain
Clinical narrative: sleeping non stop; same pain at injection site of her left arm lasting 24-48 hours after second dose; extreme fatigue since the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (sleeping non stop), VACCINATION SITE PAIN (same pain at injection site of her left arm lasting 24-48 hours after second dose) and FATIGUE (extreme fatigue since the 2nd dose) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FLUOXETINE, PROPRANOLOL, TRAZODONE, ACETIC ACID, TRETINOIN, MULTIVITAMIN [VITAMINS NOS], VITAMIN D NOS, CLINDAMYCIN and SULFAMETHOXAZOLE for an unknown indication.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced HYPERSOMNIA (sleeping non stop), VACCINATION SITE PAIN (same pain at injection site of her left arm lasting 24-48 hours after second dose) and FATIGUE (extreme fatigue since the 2nd dose). At the time of the report, HYPERSOMNIA (sleeping non stop), VACCINATION SITE PAIN (same pain at injection site of her left arm lasting 24-48 hours after second dose) and FATIGUE (extreme fatigue since the 2nd dose) outcome was unknown.            Treatment medication was not provided.   This case was linked to MOD-2021-106727 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Neck pain
Clinical narrative: neck pain; can't shake the neck pain; headache; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (can't shake the neck pain), NECK PAIN (neck pain) and HEADACHE (headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and ER2613) for COVID-19 vaccination.     No medical history was not provided by reporter.  Previously administered products included for an unreported indication: PFIZER BIONTECH COVID-19 VACCINE on 18-Mar-2021. Concomitant products included HYDROCODONE BITARTRATE, PARACETAMOL (NORCO) for an unknown indication.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 15-Apr-2021, the patient experienced HEADACHE (headache). On 26-Apr-2021, the patient experienced NECK PAIN (can't shake the neck pain). On 04-May-2021, the patient experienced NECK PAIN (neck pain). On 18-Apr-2021, HEADACHE (headache) had resolved. On 03-May-2021, NECK PAIN (can't shake the neck pain) had resolved. At the time of the report, NECK PAIN (neck pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication include  pain medication .  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Diarrhoea, Fatigue, Illness, Nausea
Clinical narrative: feeling exhausted; nausea; fever; vomiting; diarrhea; Sick for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), ILLNESS (Sick for 3 days), FATIGUE (feeling exhausted), NAUSEA (nausea) and PYREXIA (fever) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was provided by the reporter.  Concomitant products included IMMUNOGLOBULIN [IMMUNOGLOBULINS NOS] for Immune system disorder, ZOLEDRONIC ACID (RECLAST) for Osteoporosis, LURASIDONE HYDROCHLORIDE (LATUDA) for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea), ILLNESS (Sick for 3 days), FATIGUE (feeling exhausted), NAUSEA (nausea), PYREXIA (fever) and VOMITING (vomiting). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea), ILLNESS (Sick for 3 days), FATIGUE (feeling exhausted), NAUSEA (nausea), PYREXIA (fever) and VOMITING (vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Body temperature: increased (High) increased..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-114234 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow up information was  received and concomitant medications, treatment medications, new events were updated.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: feeling exhausted; nausea; fever; vomiting; diarrhea; Sick for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), ILLNESS (Sick for 3 days), FATIGUE (feeling exhausted), NAUSEA (nausea) and PYREXIA (fever) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was provided by the reporter.  Concomitant products included IMMUNOGLOBULIN [IMMUNOGLOBULINS NOS] for Immune system disorder, ZOLEDRONIC ACID (RECLAST) for Osteoporosis, LURASIDONE HYDROCHLORIDE (LATUDA) for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea), ILLNESS (Sick for 3 days), FATIGUE (feeling exhausted), NAUSEA (nausea), PYREXIA (fever) and VOMITING (vomiting). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea), ILLNESS (Sick for 3 days), FATIGUE (feeling exhausted), NAUSEA (nausea), PYREXIA (fever) and VOMITING (vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Body temperature: increased (High) increased..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-114234 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow up information was  received and concomitant medications, treatment medications, new events were updated.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Dermatitis, Lymphadenopathy, Pruritus, Rash
Clinical narrative: This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LYMPHADENOPATHY (Lymph nodes were swollen after 2-3 weeks after 2nd dose), RASH (rash), PRURITUS (itching) and DERMATITIS (Doctor described it as Dermatitis as he wasn't sure if it is coming from vaccine) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No medical history was provided by reporter. Concomitant products included LOSARTAN, APIXABAN (ELIQUIS), AMLODIPINE and SOTALOL for an unknown indication. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced RASH (rash). On 12-Mar-2021, the patient experienced LYMPHADENOPATHY (Lymph nodes were swollen after 2-3 weeks after 2nd dose). On 01-Apr-2021, the patient experienced DERMATITIS (Doctor described it as Dermatitis as he wasn't sure if it is coming from vaccine). On an unknown date, the patient experienced PRURITUS (itching). At the time of the report, LYMPHADENOPATHY (Lymph nodes were swollen after 2-3 weeks after 2nd dose), RASH (rash), PRURITUS (itching) and DERMATITIS (Doctor described it as Dermatitis as he wasn't sure if it is coming from vaccine) outcome was unknown. Not Provided. Patient was treated with Prednisone Ointment. This case was linked to MOD21-086834 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: AE contact Information Updated/lot number and date updated; Sender's Comments:  MOD21-086834:
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Ear discomfort, Paraesthesia
Clinical narrative: Tingling in the ears; Nervous problem in ears; sensation in ears; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in the ears), EAR DISCOMFORT (Nervous problem in ears) and EAR DISCOMFORT (sensation in ears) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced PARAESTHESIA (Tingling in the ears), EAR DISCOMFORT (Nervous problem in ears) and EAR DISCOMFORT (sensation in ears). At the time of the report, PARAESTHESIA (Tingling in the ears), EAR DISCOMFORT (Nervous problem in ears) and EAR DISCOMFORT (sensation in ears) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.     This case was linked to MOD-2021-106930 (Patient Link).
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chest pain, Headache, Rhinorrhoea, Visual impairment
Clinical narrative: worsened vision; runny nose; Gi upset; intermittent chest pain; headache; This spontaneous case was reported by a consumer and describes the occurrence of VISUAL IMPAIRMENT (worsened vision), RHINORRHOEA (runny nose), ABDOMINAL DISCOMFORT (Gi upset), CHEST PAIN (intermittent chest pain) and HEADACHE (headache) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced VISUAL IMPAIRMENT (worsened vision), RHINORRHOEA (runny nose), ABDOMINAL DISCOMFORT (Gi upset), CHEST PAIN (intermittent chest pain) and HEADACHE (headache). At the time of the report, VISUAL IMPAIRMENT (worsened vision), RHINORRHOEA (runny nose), ABDOMINAL DISCOMFORT (Gi upset), CHEST PAIN (intermittent chest pain) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant Medications were reported. No Treatment Information Provided.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Dizziness, Heart rate, Heart rate irregular, Hypertension
Clinical narrative: Vaccine reaction; Slight dizziness/light headedness; Blood Pressure High; Little Nauseous; Strong heart beating on chest; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (Blood Pressure High), VACCINATION COMPLICATION (Vaccine reaction), NAUSEA (Little Nauseous), HEART RATE IRREGULAR (Strong heart beating on chest) and DIZZINESS (Slight dizziness/light headedness) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004C21A and 041C21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergic to Aspirin). Concomitant products included COLCHICINE for Gout, ASCORBIC ACID (VIT C) and FISH OIL for an unknown indication.   On 04-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced HYPERTENSION (Blood Pressure High), NAUSEA (Little Nauseous) and HEART RATE IRREGULAR (Strong heart beating on chest). On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccine reaction) and DIZZINESS (Slight dizziness/light headedness). At the time of the report, HYPERTENSION (Blood Pressure High) had not resolved and VACCINATION COMPLICATION (Vaccine reaction), NAUSEA (Little Nauseous), HEART RATE IRREGULAR (Strong heart beating on chest) and DIZZINESS (Slight dizziness/light headedness) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-May-2021, Blood pressure measurement (120-80): 157/101 (High) blood pressure at 10:25AM 157/101, 157/93 (High) at 10:50AM 157/93 and 165/103 (High) at 12:13PM 165/103, 70. On 05-May-2021, Heart rate: 61 (Low) 10:25AM, 63 (Low) at 10:50 AM and 70 (normal) at 12:13 PM.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were provided by reporter.   This case was linked to MOD-2021-213383 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Non significant follow up received on 08-JUN-2021, patient demo graphics updated, events updated